| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
|
|
|
2006
|
57 |
6 |
p. 841-843
|
artikel
|
| 2 |
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies
|
Schaar, Dale
|
|
2005
|
57 |
6 |
p. 789-795
|
artikel
|
| 3 |
A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer
|
Hokita, Shuichi
|
|
2005
|
57 |
6 |
p. 736-740
|
artikel
|
| 4 |
A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer
|
Fujiwara, Keiichi
|
|
2005
|
57 |
6 |
p. 755-760
|
artikel
|
| 5 |
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases
|
Lee, Lucy
|
|
2005
|
57 |
6 |
p. 761-771
|
artikel
|
| 6 |
4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers
|
Eilender, David
|
|
2005
|
57 |
6 |
p. 719-726
|
artikel
|
| 7 |
Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells
|
Matesic, Diane F.
|
|
2005
|
57 |
6 |
p. 741-754
|
artikel
|
| 8 |
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR
|
Balin-Gauthier, Diane
|
|
2005
|
57 |
6 |
p. 709-718
|
artikel
|
| 9 |
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)
|
Ryu, Jung Su
|
|
2005
|
57 |
6 |
p. 811-818
|
artikel
|
| 10 |
Long intracellular retention of 4′-thio-arabinofuranosylcytosine 5′-triphosphate as a critical factor for the anti-solid tumor activity of 4′-thio-arabinofuranosylcytosine
|
Someya, Hitoshi
|
|
2005
|
57 |
6 |
p. 772-780
|
artikel
|
| 11 |
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
|
Marcuello, E.
|
|
2005
|
57 |
6 |
p. 835-840
|
artikel
|
| 12 |
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters
|
Samimi, Goli
|
|
2005
|
57 |
6 |
p. 781-788
|
artikel
|
| 13 |
Pharmacodynamic properties of methotrexate and AminotrexateTM during weekly therapy
|
Cole, Peter D.
|
|
2005
|
57 |
6 |
p. 826-834
|
artikel
|
| 14 |
Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours
|
Trocòniz, Iñaki F.
|
|
2005
|
57 |
6 |
p. 727-735
|
artikel
|
| 15 |
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study
|
Stathopoulos, G. P.
|
|
2005
|
57 |
6 |
p. 796-800
|
artikel
|
| 16 |
The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1α in mice
|
Koning, Barbara A. E. de
|
|
2005
|
57 |
6 |
p. 801-810
|
artikel
|
| 17 |
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice
|
Press, Rogier R.
|
|
2005
|
57 |
6 |
p. 819-825
|
artikel
|
Tijdschrift beschrijving